- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY 4.40 Å
- Oligo State
- hetero-3-3-3-3-mer
- Ligands
- 16 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 10 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA.3: 2 residues within 4Å:- Chain B: N.204, H.321
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.6: 2 residues within 4Å:- Chain B: H.299, N.301
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.10: 3 residues within 4Å:- Chain B: N.246, T.248, N.249
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.13: 2 residues within 4Å:- Chain G: N.122, K.131
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.14: 5 residues within 4Å:- Chain G: V.144, R.162, I.164, N.167, T.168
1 PLIP interactions:1 interactions with chain G- Hydrophobic interactions: G:V.144
NAG-NAG-BMA.21: 3 residues within 4Å:- Chain I: F.121, N.122, K.131
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.22: 5 residues within 4Å:- Chain I: V.144, R.162, I.164, N.167, T.168
2 PLIP interactions:2 interactions with chain I- Hydrophobic interactions: I:V.144, I:I.164
NAG-NAG-BMA.23: 1 residues within 4Å:- Chain I: N.204
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.25: 2 residues within 4Å:- Chain I: T.248, N.249
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.27: 3 residues within 4Å:- Chain I: H.299, N.301, R.412
No protein-ligand interaction detected (PLIP)- 2 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-MAN-MAN.4: 6 residues within 4Å:- Chain B: P.182, N.232, N.346, V.414, S.415
- Ligands: NAG-NAG.8
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-MAN.24: 7 residues within 4Å:- Chain I: L.231, N.232, C.347, C.413, V.414, S.415
- Ligands: NAG.51
No protein-ligand interaction detected (PLIP)- 1 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 22 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.30: 2 residues within 4Å:- Chain A: N.100, S.102
Ligand excluded by PLIPNAG.31: 2 residues within 4Å:- Chain A: N.107, E.110
Ligand excluded by PLIPNAG.32: 1 residues within 4Å:- Chain A: N.126
Ligand excluded by PLIPNAG.33: 3 residues within 4Å:- Chain A: S.17
- Chain B: E.57, N.58
Ligand excluded by PLIPNAG.34: 2 residues within 4Å:- Chain B: Q.263, N.265
Ligand excluded by PLIPNAG.35: 3 residues within 4Å:- Chain B: N.308, S.362, W.364
Ligand excluded by PLIPNAG.36: 1 residues within 4Å:- Chain B: N.324
Ligand excluded by PLIPNAG.37: 2 residues within 4Å:- Chain C: N.107, E.110
Ligand excluded by PLIPNAG.38: 1 residues within 4Å:- Chain C: N.126
Ligand excluded by PLIPNAG.39: 2 residues within 4Å:- Chain F: N.100, S.102
Ligand excluded by PLIPNAG.40: 2 residues within 4Å:- Chain F: N.107, E.110
Ligand excluded by PLIPNAG.41: 1 residues within 4Å:- Chain F: N.126
Ligand excluded by PLIPNAG.42: 2 residues within 4Å:- Chain G: Q.263, N.265
Ligand excluded by PLIPNAG.43: 3 residues within 4Å:- Chain G: K.304, N.308, E.309
Ligand excluded by PLIPNAG.44: 1 residues within 4Å:- Chain G: N.324
Ligand excluded by PLIPNAG.45: 1 residues within 4Å:- Chain G: N.361
Ligand excluded by PLIPNAG.46: 2 residues within 4Å:- Chain G: P.261, N.416
Ligand excluded by PLIPNAG.47: 3 residues within 4Å:- Chain F: S.17
- Chain I: E.57, N.58
Ligand excluded by PLIPNAG.48: 2 residues within 4Å:- Chain I: Q.263, N.265
Ligand excluded by PLIPNAG.49: 2 residues within 4Å:- Chain I: K.304, N.308
Ligand excluded by PLIPNAG.50: 1 residues within 4Å:- Chain I: N.324
Ligand excluded by PLIPNAG.51: 3 residues within 4Å:- Chain I: P.261, N.416
- Ligands: NAG-NAG-BMA-MAN-MAN.24
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Escolano, A. et al., Immunization expands B cells specific to HIV-1 V3 glycan in mice and macaques. Nature (2019)
- Release Date
- 2019-06-12
- Peptides
- RC1 variant of HIV-1 Env glycoprotein gp41: ACF
RC1 variant of HIV-1 Env glycoprotein gp120: BGI
Ab897NHP antibody Fab heavy chain: DHJ
Ab897NHP antibody Fab light chain: EKL - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
CF
FB
BG
GI
ID
DH
HJ
JE
EK
KL
L
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY 4.40 Å
- Oligo State
- hetero-3-3-3-3-mer
- Ligands
- 16 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 10 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 2 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 1 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 22 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Escolano, A. et al., Immunization expands B cells specific to HIV-1 V3 glycan in mice and macaques. Nature (2019)
- Release Date
- 2019-06-12
- Peptides
- RC1 variant of HIV-1 Env glycoprotein gp41: ACF
RC1 variant of HIV-1 Env glycoprotein gp120: BGI
Ab897NHP antibody Fab heavy chain: DHJ
Ab897NHP antibody Fab light chain: EKL - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
CF
FB
BG
GI
ID
DH
HJ
JE
EK
KL
L